Last reviewed · How we verify
NCT03699800
Graphomotor Intervention Program for Handwriting Difficulties Prevention in School-Age
NA trial testing Graphomotor intervention program in Typical Development in 47 participants. Completed in 31 December 2019.
31 December 2019
Quick facts
| Lead sponsor | University of Évora |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 47 |
| Start date | 15 October 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Graphomotor intervention program
Conditions studied
- Typical Development — all drugs for Typical Development →
- Risk of Dysgraphia — all drugs for Risk of Dysgraphia →
- Dysgraphia — all drugs for Dysgraphia →
Sponsor
University of Évora
Who can join
Adults 7 to 7, any sex, with Typical Development or Risk of Dysgraphia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
12-30% of children present handwriting difficulties, which has negative repercussions on their school career. For this reason, it is fundamental to bet on their prevention. The aim of present study is to examine the effects of a graphomotor intervention program on quality and speed of handwriting in second-grade children. This experimental study is a randomized controlled trial. The program will run for 8 weeks (2 sessions/week of 30 minutes), followed by 6 months of follow-up without intervention. Participants will be assessed 1) at baseline, 2) at the end of the program, and 3) after the follow-up. Participants will be randomly allocated to two groups: experimental group (graphomotor intervention program) and control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03699800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Graphomotor intervention program
Trials testing the same drug.
- NCT03699787 — Graphomotor Intervention Program for Handwriting Difficulties Prevention in Preschool Age · NA · completed
Other recruiting trials for Typical Development
Currently open trials in the same condition.
- NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
- NCT04631042 — Developing Brain, Impulsivity and Compulsivity · recruiting
Other University of Évora trials
Trials by the same sponsor.
- NCT07355179 — PLAY UP: An Intervention Program Through Active Play and Environmental Affordances · NA · enrolling by invitation
- NCT06943651 — Empowering Healthy Lifestyle Behavior to Prevent and Control Obesity in Young Adults · NA · not yet recruiting
- NCT06933121 — Empowering Healthy Lifestyle Behaviour Through Personalised Intervention Portfolios to Prevent and Control Obesity in Ch · NA · not yet recruiting
- NCT06802484 — Comparing the Effects of Multicomponent Exercise on Cardiovascular Health and Lipid Profiles in Premenopausal and Postme · NA · completed
- NCT06442878 — Benefits of a Belly Dance Psychomotor Intervention · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03699800 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Évora
- Last refreshed: 27 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03699800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing